Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Bionano Genomics, Inc.
BNGO
Core
Clinical Trial Result
Other
Publication Positive
Interim Data Positive
Patient Retention High
Ai Diagnostics Investment
Other
Liquidity Position Snapshot Disclosed
Amendment Modification Waiver Clause
Ip Assignment To Company
Rsu Psu Vesting Schedule Disclosed
Net Loss Reported
Financing Activities Cash Flow Disclosure
Other Income Expense Disclosure
Section 409A Compliance Statement
Termination For Material Breach Clause
Depreciation Expense Composition Disclosure
Confidential Information Definition
Sga Expense Comparison Disclosed
Personnel Cost Decrease Disclosure
Corporate Authority Representation
Ipo Or Capital Raising Completion
Other
Gross Margin Comparison Disclosed
Publication Positive
Kol Endorsement
Core
Clinical Trial Result
Healthcare
Volume Inflecting
Other
Kol Endorsement
Other
Autocallable Structured Note Offering
Other
Classified Board Director Election
Auditor Appointment Ratification
Quorum Presence Disclosed
Other
Liquidity Position Snapshot Disclosed
Rsu Psu Vesting Schedule Disclosed
Net Loss Reported
Financing Activities Cash Flow Disclosure
Other Income Expense Disclosure
Sga Expense Comparison Disclosed
Ipo Or Capital Raising Completion
Cash Flow Statement Investing Activities
Revenue Increase Attribution Disclosure
Personnel Cost Decrease Disclosure
Interest Income Year Over Year Comparison
Restructuring Initiated
Shares Outstanding Disclosure
Business Services
Demand Softening
SaaS
Recurring Revenue Growing
Other
Gross Margin Comparison Disclosed
Burn Rate Controlled
Core
Management Exodus
Other
Executive Transition Gratitude Statement
Kol Endorsement
Classified Board Director Election
Director Continuity Stated